Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

NCT01099774 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

597

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Bimatoprost 0.03% Formulation B Ophthalmic Solution
DRUG: Bimatoprost 0.03% Ophthalmic Solution

Sponsor

Allergan